Pages that link to "Q24250213"
Jump to navigation
Jump to search
The following pages link to Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Q24250213):
Displaying 50 items.
- Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/chronic lung disease (Q24245471) (← links)
- The Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761] (Q24563293) (← links)
- Retinopathy of prematurity and risk factors: a prospective cohort study (Q24810958) (← links)
- Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity (Q26772889) (← links)
- Chorioamnionitis and Patent Ductus Arteriosus: A Systematic Review and Meta-Analysis (Q26786505) (← links)
- An update on pharmacologic approaches to bronchopulmonary dysplasia (Q26825139) (← links)
- Bronchopulmonary dysplasia: an update (Q28285868) (← links)
- Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. (Q30238696) (← links)
- Discharge outcomes of extremely low birth weight infants with spontaneous intestinal perforations (Q30438837) (← links)
- Update on Cochrane data on paediatric respiratory diseases (Q30814020) (← links)
- Postnatal steroid treatment and brain development (Q30907696) (← links)
- Pentoxifylline in preterm neonates: a systematic review (Q33391658) (← links)
- Evidence based care (Q33584708) (← links)
- Decreasing incidence of chronic lung disease despite the gradual reduction of postnatal dexamethasone use in very low birth weight infants (Q33631717) (← links)
- Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants (Q33758531) (← links)
- (Q33907398) (redirect page) (← links)
- Oxidative stress in the developing brain: effects of postnatal glucocorticoid therapy and antioxidants in the rat. (Q33941213) (← links)
- Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years (Q33962521) (← links)
- A psychoneuroimmunologic examination of cumulative perinatal steroid exposures and preterm infant behavioral follow-up (Q34224396) (← links)
- Cumulative perinatal steroids: child development of preterm infants (Q34353377) (← links)
- Drug therapy for the prevention and treatment of bronchopulmonary dysplasia (Q35087324) (← links)
- Neurocognitive outcome after very preterm birth (Q35294356) (← links)
- Postnatal corticosteroids for prevention and treatment of chronic lung disease in the preterm newborn (Q35294711) (← links)
- State of the Science: Achievements and Challenges Across the Spectrum of Care for Preterm Infants (Q35562560) (← links)
- Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia (Q35675944) (← links)
- Effects of postnatal dexamethasone or hydrocortisone in a rat model of antenatal lipopolysaccharide and neonatal hyperoxia exposure (Q35859232) (← links)
- Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use. (Q35989387) (← links)
- Scoring method for early prediction of neonatal chronic lung disease using modified respiratory parameters (Q36161938) (← links)
- Necrotising enterocolitis and localised intestinal perforation: different diseases or ends of a spectrum of pathology (Q36493313) (← links)
- Dopamine-resistant hypotension and severe retinopathy of prematurity (Q36913261) (← links)
- Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia? (Q36915832) (← links)
- How has research in the past 5 years changed my clinical practice (Q36915841) (← links)
- Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook (Q37070364) (← links)
- Glucocorticoids and neonatal brain injury: the hedgehog connection. (Q37073741) (← links)
- Postnatal corticosteroids for bronchopulmonary dysplasia (Q37145554) (← links)
- Chronic lung disease in newborns (Q37184519) (← links)
- Nephrocalcinosis in preterm neonates. (Q37271752) (← links)
- Novel treatments for NEC: keeping IBD in mind (Q38012671) (← links)
- Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology (Q38538932) (← links)
- Hazards of systemic steroids for ventilator-dependent preterm infants: what would a parent want? (Q39432755) (← links)
- Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone (Q40370995) (← links)
- Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies. (Q40479808) (← links)
- Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials (Q40489148) (← links)
- Relevance of clinical features in the prognosis of bronchopulmonary dysplasia in premature infants (Q42376361) (← links)
- Stopping the swinging pendulum of postnatal corticosteroid use. (Q43160711) (← links)
- Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. (Q44875030) (← links)
- Efficacy of glucocorticoids, vitamin A and caffeine therapies for neonatal mortality in preterm infants: a network meta-analysis (Q47139802) (← links)
- Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. (Q47235844) (← links)
- The rate and pattern of bronchopulmonary dysplasia in Kuwait (Q47942459) (← links)
- (Q57692316) (redirect page) (← links)